Evidence map›Paper›PMID 33868420›Full record

ArticlePostepy w kardiologii interwencyjnej = Advances in interventional cardiology2021

Twelve-month outcomes of transapical transcatheter aortic valve implantation in patients with severe aortic valve stenosis.

Łukasz Wiewiórka, Robert Sobczyński, Jarosław Trębacz, Jerzy Sadowski, Dariusz Dudek, Maciej Stąpór, Janusz Konstanty-Kalandyk, Robert Musiał, Andrzej Gackowski, Krzystof Malinowski and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Postepy w kardiologii interwencyjnej = Advances in interventional cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Łukasz WiewiórkaDepartment of Interventional Cardiology, John Paul II Hospital, Krakow, Poland.
Robert SobczyńskiDepartment of Cardiac Surgery and Transplantation, John Paul II Hospital, Krakow, Poland.
Jarosław TrębaczDepartment of Interventional Cardiology, John Paul II Hospital, Krakow, Poland.
Jerzy SadowskiJagiellonian University Medical College, Institute of Cardiology, Department of Cardiac Surgery and Transplantation, John Paul II Hospital, Krakow, Poland.
Dariusz DudekJagiellonian University Medical College, Institute of Cardiology, Krakow, Poland.
Maciej StąpórDepartment of Interventional Cardiology, John Paul II Hospital, Krakow, Poland.
Janusz Konstanty-KalandykJagiellonian University Medical College, Institute of Cardiology, Department of Cardiac Surgery and Transplantation, John Paul II Hospital, Krakow, Poland.
Robert MusiałDepartment of Anaesthesiology and Intensive Therapy, John Paul II Hospital, Krakow, Poland.
Andrzej GackowskiNonivasive Cardiovascular Laboratory, John Paul II Hospital, Krakow, Poland.
Krzystof Malinowski2 Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland.
Paweł KleczyńskiJagiellonian University Medical College, Institute of Cardiology, Department of Interventional Cardiology, John Paul II Hospital, Krakow, Poland.
Krzysztof ŻmudkaJagiellonian University Medical College, Institute of Cardiology, Department of Interventional Cardiology, John Paul II Hospital, Krakow, Poland.
Bogusław KapelakJagiellonian University Medical College, Institute of Cardiology, Department of Cardiac Surgery and Transplantation, John Paul II Hospital, Krakow, Poland.
Jacek LegutkoJagiellonian University Medical College, Institute of Cardiology, Department of Interventional Cardiology, John Paul II Hospital, Krakow, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTransapical access (TA) transcatheter aortic valve implantation (TAVI) (TA-TAVI) represents one of the possible routes in patients with severe aortic stenosis (AS) who are not suitable for transfemoral access.

aimTo assess early- and mid-term clinical outcomes after TA-TAVI. MATERIAL AND

methodsPatients with severe symptomatic AS undergoing TA-TAVI from November 2008 to December 2019 were enrolled. Clinical and procedural characteristics as well as clinical outcomes including all-cause mortality during 12-month follow-up were assessed.

resultsSixty-one consecutive patients underwent TA-TAVI for native AS. Patients were elderly with median age of 80.0 (76.0-84.0) years; 55.7% were males. Median baseline EuroSCORE I and STS scores were 18.2% (11.6-27.7) and 4.8% (3.3-8.2), respectively. The procedural success rate was 96.7%. In-hospital, 30-day and 12-month mortality rates were 9.8%; 18.0% and 24.6%, respectively. The main periprocedural and in-hospital complications were bleeding complications (14.8%). The following factors were associated with 12-month mortality: previous cerebrovascular event (CVE), glomerular filtration rate (GFR), aortic valve area (AVA), right ventricular systolic pressure (RVSP) and serum level of N-terminal prohormone of brain natriuretic peptide (NT-proBNP) (RR for CVE 3.17, 95% confidence interval (CI): 1.15-8.76:

conclusionsTransapical TAVI in high-risk patients provides good hemodynamic results with acceptable outcomes.

Indexed as

aortic stenosishigh-risk patientsoutcomestransapicaltranscatheter aortic valve implantation

Identifiers

PMID33868420
PMCPMC8039915

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.